Recursion Pharmaceuticals (RXRX) EBITDA Margin Growth (1y) (2021 - 2026)
Recursion Pharmaceuticals (RXRX) EBITDA Margin Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3,609.00 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1,536.00 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Recursion Pharmaceuticals | 1.71 Bn | 1.05 Bn | -6.02 Mn | -68,770.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -68,770.00 |
| Dec 31, 2025 | 373,757.00 |
| Sep 30, 2025 | -296,011.00 |
| Jun 30, 2025 | -24,019.00 |
| Mar 31, 2025 | -63,544.00 |
| Dec 31, 2024 | -313,405.00 |
| Sep 30, 2024 | 51,564.00 |
| Jun 30, 2024 | 1,987.00 |
| Mar 31, 2024 | -12,403.00 |
| Dec 31, 2023 | -46,246.00 |
| Sep 30, 2023 | -40,762.00 |
| Jun 30, 2023 | 16,610.00 |
| Mar 31, 2023 | 51,133.00 |
| Dec 31, 2022 | 211,864.00 |
| Sep 30, 2022 | 135,570.00 |
| Jun 30, 2022 | 74,315.00 |
| Mar 31, 2022 | 14,014.00 |
| Dec 31, 2021 | -161,393.00 |
| Sep 30, 2021 | 36,141.00 |
| Jun 30, 2021 | 818,840.00 |